FizyoArt LogoFizyoArt

Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.

Granulomatosis with Polyangiitis (GPA)

What is granulomatosis with polyangiitis (GPA), what symptoms does it cause, how is it diagnosed, and how is it treated? A comprehensive guide based on reliable sources.

Granulomatosis with polyangiitis is a type of vasculitis that can affect small- and medium-sized blood vessels and may involve many organs, especially the lungs, sinuses, and kidneys. Early diagnosis matters because untreated disease can lead to organ damage, but with current treatment options the disease can be brought under control in many people.

What is granulomatosis with polyangiitis (GPA)?

Granulomatosis with polyangiitis is a rare vasculitis in which the immune system reacts inappropriately against blood vessel walls and can affect small- and medium-sized vessels. The disease most often involves the ear-nose-throat region, lungs, and kidneys, but it can also affect the skin, eyes, nervous system, and joints. Its former name was Wegener granulomatosis, but current usage prefers granulomatosis with polyangiitis, or GPA for short. Since untreated cases can lead to loss of organ function, early evaluation is important. [1][2][3]

GPA often begins insidiously, and its first signs may resemble a simple upper respiratory infection. Long-lasting nasal congestion, crusting, frequent sinusitis, ear problems, persistent cough, shortness of breath, fatigue, joint pain, or blood in the urine appearing together may lead a doctor to consider vasculitis. Because the disease does not look the same in everyone, diagnosis can be difficult; that is why evaluating it with a “one symptom, one disease” logic can be misleading. [1][2][3]

What are the symptoms?

The symptom spectrum varies according to the organ involved. People with nasal and sinus involvement may have long-lasting cold-like symptoms, recurrent sinusitis, nosebleeds, crusting, or reduced sense of smell. Lung involvement may cause cough, sputum, chest pain, shortness of breath, and sometimes bloody sputum. Kidney involvement may not cause obvious symptoms at first; despite that, blood or protein leakage into the urine and worsening kidney function may progress. This silent kidney involvement explains why regular laboratory evaluation is so important. [1][2][5]

In addition, fever, unintentional weight loss, fatigue, muscle-joint pain, skin rash or bruising, eye redness-pain, numbness, and weakness may occur as systemic findings. Rapidly increasing shortness of breath, bloody sputum, marked kidney dysfunction, reduced vision, or serious neurological complaints require urgent evaluation. Although GPA is rare, it can progress quickly, so new symptoms affecting multiple systems should be taken seriously. [1][2][4]

What causes it, and are there risk factors?

No single cause has been established for GPA. Current knowledge suggests an autoimmune process that develops when genetic susceptibility and immune triggers come together. The disease belongs to the group of ANCA-associated vasculitides, and PR3-ANCA may be detected in some people, but this test alone does not make the diagnosis. In other words, ANCA positivity gains meaning only together with the clinical picture and other findings; a negative result also does not completely rule the disease out. [3][4][5]

A specific lifestyle factor has not been clearly proven as the sole main cause of GPA. Still, it is common for symptoms to become noticeable after periods resembling upper respiratory infection. The person’s age, other illnesses, and the organs involved can affect the course of disease. The key determinant is reaching diagnosis and treatment before organ involvement causes lasting damage. For that reason, rather than focusing on “risk,” it is more important to recognize possible warning signs on time and seek specialties such as rheumatology or nephrology when needed. [1][2][4]

How is it diagnosed?

GPA is not diagnosed by looking at a single blood test. The doctor first takes a detailed history and performs an examination, then orders blood tests, inflammatory markers, kidney function tests, urinalysis, ANCA testing, and imaging according to organ involvement. Chest X-ray or CT, sinus imaging, and kidney evaluation may all be used in this process. In many cases, a urine test revealing silent kidney involvement is clinically very valuable. [2][3][5]

A biopsy is required in some patients to confirm the diagnosis. A sample taken from the nasal mucosa, lung, kidney, or another involved tissue helps demonstrate the inflammatory pattern and vascular involvement. The purpose of diagnosis is not only to confirm GPA, but also to exclude infection, other connective tissue diseases, cancers, and other vasculitis causes. That is why diagnosis sometimes requires joint evaluation by several specialties. Individual medical assessment is essential; online information does not replace diagnosis. [1][3][4]

What are the treatment options?

The treatment plan depends on whether the disease is life-threatening or organ-threatening and on which organs are involved. In active disease that threatens life or organs, glucocorticoids and immunosuppressive treatments such as rituximab or cyclophosphamide may be used. In recent years, guidelines have placed more emphasis in some situations on strategies to reduce glucocorticoid burden and on maintenance treatment. Treatment has two main goals: to suppress active inflammation quickly and then prevent relapse. [4][5]

In milder or more limited disease, the approach may be different, but treatment should still always be planned under specialist supervision. Because medications can affect infection risk, bone health, blood sugar, blood pressure, and liver-kidney tests, regular follow-up is required. People with kidney involvement need nephrology follow-up, while those with lung involvement benefit from respiratory evaluation. Even after the disease is brought under control, flares may occur; for that reason, medication changes or discontinuation should not be decided by the patient alone. [1][4][5]

Possible complications and when to see a doctor

The most serious complications include kidney failure, lung bleeding, permanent hearing or vision problems, nerve damage, and treatment-related infections. The combination of long-term inflammation and intense immunosuppression means that people may be affected both by the disease and by side effects of treatment. That is why GPA follow-up should not be thought of as something that “ends once symptoms pass”; monitoring continues with regular urine tests, kidney function tests, blood counts, and imaging when needed. [1][4][5]

Urgent care is needed for bloody sputum, rapidly increasing shortness of breath, reduced urine output, newly developed severe leg or arm weakness, sudden change in vision, high fever, or signs of serious infection. Milder but persistent nasal-sinus complaints, a cough that does not resolve, change in urine color, or unexpected weight loss should also not be ignored. Early treatment may reduce the risk of organ damage; for that reason, specialist evaluation should not be delayed when suspicious findings appear. [1][2][3]

Lifestyle and follow-up

Lifestyle changes do not treat GPA on their own, but they can support general well-being. Not smoking, taking hygiene measures to reduce infection risk, discussing vaccinations with the treatment team, and staying in follow-up for bone health and cardiometabolic risks are important. In people using long-term steroids, nutrition, exercise, and bone-protective measures also need separate consideration. [1][4][5]

The disease may follow a fluctuating course. For that reason, even fatigue or mild complaints may sometimes be signs of relapse. Still, not every complaint directly means a flare; infection, medication side effects, or other causes may also explain the picture. The safest approach is to share new symptoms with the doctor who regularly follows the disease and not miss planned checkups. GPA is a disease that can be managed with specialist care but requires attention because of its seriousness. [1][2][4]

Personal medical evaluation is important for symptoms that are prolonged, progressive, or clearly affecting daily life; this content does not replace diagnosis and treatment. [1]

3) FAQ

Can granulomatosis with polyangiitis be cured?

GPA can be brought under control in many people with appropriate treatment, but it is followed as a chronic disease that may relapse. Treatment response varies according to the organs involved and how early the diagnosis is made. [1][4][5]

Does GPA turn into cancer?

No. GPA is not a cancer; it is an autoimmune disease involving inflammation of blood vessels. However, during diagnosis, other causes—including infections and some cancers—may need to be excluded. [2][3][4]

If the ANCA test is negative, does that mean it cannot be GPA?

No. ANCA testing helps in diagnosis, but it is not decisive on its own; some people may test negative. Clinical findings, urine tests, imaging, and biopsy when necessary are evaluated together. [3][4][5]

Which symptoms require emergency care?

Bloody sputum, severe shortness of breath, marked reduction in urine output, sudden visual changes, or high fever require urgent evaluation. [1][2]

How long does treatment last?

The duration varies from person to person. Usually, more intensive treatment is given first to achieve remission, followed by maintenance treatment to prevent relapse. The exact duration depends on disease extent and the medications used. [4][5]

References

  1. 1.Vasculitis Foundation. Granulomatosis with Polyangiitis (GPA) Patient Guide, 2024. https://vasculitisfoundation.org/wp-content/uploads/2024/03/2024-VF_GPA_Weg-Brochure.pdf
  2. 2.NHS. Granulomatosis with polyangiitis (GPA). https://www.nhs.uk/conditions/granulomatosis-with-polyangiitis/
  3. 3.MedlinePlus. Granulomatosis with polyangiitis. https://medlineplus.gov/granulomatosiswithpolyangiitis.html
  4. 4.Hellmich B, et al. EULAR recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2024. https://ard.bmj.com/content/83/1/30
  5. 5.KDIGO. Clinical Practice Guideline for ANCA-Associated Vasculitis, 2024. https://kdigo.org/wp-content/uploads/2024/02/KDIGO-2024-ANCA-Vasculitis-Guideline.pdf